Indaptus Therapeutics (INDP) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.77

DCF Value+199.35%

$8.29

Potential upside vs current price

Current Stock Price

$2.77

DCF Value+199.35%

$8.29

Potential upside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.77

DCF Value+199.35%

$8.29

Potential upside vs current price

Current Stock Price

$2.77

DCF Value+199.35%

$8.29

Potential upside vs current price

Indaptus Therapeutics, Inc.